Dr. Suzanne Topalian

“Our continuing studies to profile T cells recognizing virus-positive vs virus-negative MCCs will build on these initial findings to provide an in-depth characterization of the immune response against MCCs.  We anticipate that such work may lead to enhanced therapeutics and immune monitoring tools. Please know how much NFCR funding is appreciated in support of these investigations.”

– Dr. Suzanne Topalian, NFCR-Supported Scientist at Johns Hopkins University